
Every day, an army of researchers from America’s biopharmaceutical companies fight to end disease. Their indomitable will to find the unfindable and cure the incurable is the driving engine behind every medical achievement to transform the way we prevent and treat disease and help patients live longer, healthier lives.
LATEST ARTICLES
-
Researcher Profile: Amy Richards
Amy’s father sparked her love of science as a child, and that passion inspires her work today at Sanofi.
-
Researcher Profile: Dr. Yasmeen Agosti
At Pfizer, Yasmeen works to develop maternal vaccines that have the potential to help prevent diseases from affecting at-risk infants.
-
Researcher Profile: Stephanie Bartner
Stephanie’s interest in becoming a research analyst for Sanofi was personal.
-
Researcher Profile: Alice Walsh
Alice from Bristol-Myers Squibb shares how she uses data to better inform how we study disease and improve patient care.
-
Researcher Profile: Craig Mickanin
A biopharmaceutical researcher at Novartis, Craig has spent most of his two-decade career studying cell and gene therapies.
-
Researcher Profile: Jim Martinez, MD
Promising results from clinical trials of CGRP inhibitors bring renewed hope for patients with cluster headache.
-
Researcher Profile: Dr. Joel Trugman
Joel and biopharmaceutical researchers like him work to develop new therapies that prevent migraines before they start.
-
Researcher Profile: David Roth, MD
Dr. David Roth is part of the GSK team studying lupus treatments with the hope of finding a cure.
-
There Are No Failures in Parkinson’s Research; Only Setbacks
Parkinson’s disease can’t be slowed or cured, but researchers like Dr. Williamson are working to change that.
-
Researcher Profile: Steve Yancey
Steve Yancey and his team work to discover new and better treatments that address the needs of severe asthma patients.
-
Researcher Profile: René van der Merwe
Biologics could bring an end to today’s “one size fits all” approach to treating asthma says René van der Merwe.
-
Researcher Profile: Roland Kolbeck
Dr. Kolbeck led a team of researchers to develop what has become AstraZeneca’s first respiratory biologic treatment.
-
Researcher Profile: Dr. Marie-Claire Peakman
Dr. Marie-Claire Peakman always knew she wanted to make a difference in the world.
-
Researcher Profile Rino Rappuoli
Dr. Rino Rappuoli, a scientist at GSK, has helped pioneer vaccines that can help prevent meningococcal meningitis.
-
Researcher Profile: Andrea Fanjul
For Dr. Andrea Fanjul and a team of scientists at Takeda, it’s the patients and their stories that bring purpose to their work.
-
Researcher Profile: Gokul Swaminathan
Dr. Gokul Swaminathan of Merck researches potential vaccines that can train the body to recognize and kill a pathogen before it ever leads to an infection.
-
Researcher Profile: Rebecca Leary
Rebecca Leary works at the forefront of precision medicine, pursuing technologies that characterize cancer cells and their relationship with the body's own immune system.
-
Researcher Profile: Christina Kiley
Through her roles at Eli Lilly and Company, Dr. Christina Kiley developed a strong understanding of the patient perspective and the diverse ways patients are incorporated into biopharmaceutical research.
-
Researcher Profile: Eddy Han-Burgess
Eddy Han-Burgess and his team are using a mix of mathematical modeling, big data and artificial intelligence in hopes of more quickly identifying the unique characteristics of someone’s condition.
-
Researcher Profile: Henrik Klitgaard
With nearly 30 years of experience in biopharmaceutical research, Dr. Henrik Klitgaard has dedicated his life to pursuing new and better treatments for patients with epilepsy.
-
Researcher Profile: David Cobden
Learn about what America's biopharmaceutical companies are doing to ensure we can continue to afford innovation by reading the story of David Cobden, Ph.D., who works to pursue new payment models for a variety of cutting-edge treatments.
-
Researcher Profile: Michael Pride
To demonstrate the incredible work pursued by America's biopharmaceutical researchers, we're sharing the story of Dr. Michael Pride, a Pfizer scientist who is working on preventative vaccines for the bacterium Clostridium difficile (C. difficile).
-
Researcher Profile: Niranjana Nagarajan
According to Dr. Niranjana Nagarajan, a principal scientist at Celgene, "sheer curiosity" drove her into biopharmaceutical research.
-
Researcher Profile: Nils Lonberg
In his role as senior vice president of oncology biology discovery at Bristol-Myers Squibb, Dr. Lonberg leads a drug discovery group responsible for identifying potential immuno-oncology (I-O) treatments.
-
Researcher Profile: Doug Williamson
In recognition of the great work being done to treat mental illness, we're sharing the story of Doug Williamson, MD, the chief medical officer and vice president of US Medical at Lundbeck, who has a long career researching treatments for a variety of mental health conditions.
-
Researcher Profile: Jay Fine
A new study shows there are more than 300 medicines in development to treat skin diseases. At Boehringer Ingelheim, researchers like Dr. Jay Fine are dedicated to finding innovative approaches to treating these diseases.
-
Researcher Profile: Jane Owens
Dr. Owens is a senior director who manages rare muscle disease research projects in Pfizer's Rare Disease Research Unit.
-
Researcher Profile: Jirong Lu
Dr. Jirong Lu, a distinguished research fellow at Eli Lilly and Company (Lilly), traces the beginnings of her career to a high school fascination with chemistry.
-
Researcher Profile: Rajeev Venkayya
Dr. Rajeev Venkayya joined Takeda in 2012, to launch the company's global vaccine business.
-
Researcher Profile: Axel Hoos
"In simple terms, we're making new medicines that can have a transformational impact on cancer," says Dr. Axel Hoos about his day-to-day work.
-
Researcher Profile: Luiz Miguel Camargo
As director of innovation networks at UCB, Dr. Luiz Miguel Camargo helps identify tools that researchers use to discover transformative medicines.
-
Researcher Profile: Victor Sloan
As vice president and development strategy lead at UCB, Victor Sloan has worked in the field of rheumatology since the early 1990's.
-
Researcher Profile: Carla Canuso
Carla Canuso started her career as a psychiatric nurse working with patients suffering from schizophrenia and other mental illnesses.
-
Researcher Profile: Maysoun Shomali
As a research investigator at Sanofi, Maysoun Shomali is a pioneer making a difference for breast cancer research.
-
Researcher Profile: Eva Kohegyi
Dr. Eva Kohegyi specializes in research for medications in neurologic and psychiatric indications, including the development of treatments for patients with Alzheimer's disease, Tourette's disease, schizophrenia, bipolar disorder and other illnesses of the central nervous system.
-
Researcher Profile: Tim Reilly
As vice president of oncology early asset development at Bristol-Myers Squibb (BMS), Dr. Tim Reilly leads a team of researchers who are pursuing the next generation of medicines to fight cancer.
-
Researcher Profile: Kelly Knee
As a principal scientist working on sickle cell disease in the Rare Disease Research Unit (RDRU) at Pfizer, Kelly Knee is a jack of all trades.
-
Researcher Profile: Wayne Drevets
Dr. Drevets is a scientist at Janssen Research & Development, LLC, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, where he oversees the development of new treatments for mood disorders, such as major depressive disorder, treatment resistant depression and suicidality.
-
Researcher Profile: Brian Johns
Dr. Brian Johns is currently the vice president of HIV Research at GlaxoSmithKline (GSK), where he leads a team of 24 biopharmaceutical researchers to investigate new ways of treating and preventing HIV/AIDS.
-
Researcher Profile: Laura Michael
Dr. Laura Michael started her career at Lilly researching cardiovascular disease and the complications that frequently arise from it.
-
Researcher Profile: Ian Reynolds
Ian leads the Small Molecule Discovery Group at Teva Pharmaceuticals, where he is focused on drug discovery for neurological and neurogenerative diseases, such as Parkinson’s and multiple sclerosis (MS).
-
Researcher Profile: Paul Nioi
Paul is a scientist in the Research and Development Group at Amgen where he is focused largely on the development of novel approaches for evaluating potential new medicines using genetics, including recent scientific breakthroughs in heart disease.
-
Researcher Profile: Matthew Kennedy
Matt has spent the majority of his nearly 20-year career in drug discovery searching for a cure to one of the most challenging diseases, Alzheimer's.
-
Researcher Profile: Pablo Sardi
Dr. Pablo Sardi is a Research and Development director in the Neurobiology Unit at Sanofi. He started his career in Boston doing post-doctoral research at Harvard and moved to Genzyme in 2007 to pursue his interest in investigating disease mechanism to develop therapies to treat neurodegenerative diseases.
-
Researcher Profile: Jennifer Allport-Anderson
Dr. Allport-Anderson works to find new medicine for cardiovascular metabolic diseases, which can lead to health problems such as heart attacks and diabetes.
-
Researcher Profile: Salim Mujais
Salim and his team at Astellas serve as the bridge between drug discovery and drug delivery.
-
Researcher Profile: Tom Marsilje
It was supposed to be one of the best days of Tom Marsilje's life. After years of hard work and determination, the research team he was a member of had developed a new drug to treat lung cancer.
-
Researcher Profile: Christina Trout
Christina works in the Epigenetic Department at Celgene as a research scientist, exploring a number of cancer indications.
-
Researcher Profile: Darryle Schoepp
Darryle Schoepp has been involved in drug research for over 30 years, and wears many hats at Merck.
-
Researcher Profile: Eric Rubin
A medical oncologist by training, Dr. Rubin has focused on cancer drug development for almost two decades.
-
Researcher Profile: Kevin Grove
“My job is to help discover the next generation of therapeutics that will help treat millions of patients dealing with obesity.” For Kevin Grove, an academic research scientist turned industry leader on obesity, discovery is all about collaboration.
-
Researcher Profile: Anita Gandhi
Dr. Anita Gandhi has worked at Celgene since 2002. In her current role, Dr. Gandhi is a translational scientist and develops drugs in the early stages of development and assesses which patients would benefit the most from them
-
Researcher Profile: Dan Skovronsky
A neuroscientist and neuropathologist by training, Dan is responsible for development across all of Lilly's products - from clinical trials through approvals - specifically working within the areas of oncology, diabetes, Alzheimer's disease, immunology and pain management.
RELATED ARTICLES
This Scientist Is Working to Develop a Potential COVID-19 Vaccine
Janssen is one among dozens of biopharmaceutical companies working around the clock to identify and develop safe and effective vaccines to prevent COVID-19.
Researcher Profile: Dr. Ryan Moslin
Researchers like Ryan at Bristol-Myers Squibb are making strides in lupus treatment that were impossible 10 years ago.
Fighting for Reform: The Honorable Steven Leifman
The Honorable Steven Leifman worked to transform the criminal justice system of Florida to better help - not hinder - the treatment of mental health inmates in Southern Florida.